LEADER 03166nam  2200937z- 450 
001 9910367751903321
005 20231214133455.0
010   $a3-03921-677-5
035   $a(CKB)4100000010106198
035   $a(oapen)https://directory.doabooks.org/handle/20.500.12854/54599
035   $a(EXLCZ)994100000010106198
100   $a20202102d2019      |y         0
101 0 $aeng
135   $aurmn|---annan
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aNew Lipid Lowering Therapies for Cardiovascular and Metabolic Diseases: Lessons from the Past and Future Challenges
210   $cMDPI - Multidisciplinary Digital Publishing Institute$d2019
215   $a1 electronic resource (116 p.)
311   $a3-03921-676-7 
330   $aThis book illustrates some of the most recent research efforts that have been made in lowering plasma cholesterol levels in patients with CVD. Selected articles aimed to illuminate advances and urgent challenges in the management of CVD, including disease management using statin-combined therapeutic strategies.
517   $aNew Lipid Lowering Therapies for Cardiovascular and Metabolic Diseases
610   $aapolipoprotein
610   $alipids
610   $arisk stratification
610   $aproprotein convertase subtilisin-kexin type 9 (PCSK9)
610   $avaspin
610   $asphingolipids
610   $aPCSK9
610   $aceramides
610   $aatrial fibrillation
610   $acircular RNA
610   $aSTEMI
610   $acholesterol
610   $alipoproteins
610   $acardiovascular disease (CVD)
610   $acoronary artery bypass grafting
610   $aatherosclerosis
610   $astatin
610   $aLDL subfractions
610   $aacute kidney injury
610   $adyslipidemia
610   $agene expression
610   $aNSTEMI
610   $aNAFLD
610   $ahyperlipidemia
610   $anonstatin
610   $acholesteryl ester transfer protein
610   $alow-density lipoprotein cholesterol
610   $aanacetrapib
610   $aHDL
610   $aacute coronary syndrome
610   $amiRNA
610   $acardiovascular risk
610   $apleiotropic actions
610   $agenetic
610   $aABCA1
610   $asdLDL
610   $acardiovascular disease
610   $aproprotein convertase subtilisin/kexin type 9
610   $ainclisiran
610   $areverse cholesterol transport
610   $asterol
610   $asmall interfering RNA (siRNA)
610   $aRNA-binding proteins
610   $acardiovascular diseases
610   $aNASH
610   $alow-density lipoprotein-cholesterol (LDL-C)
610   $astroke
610   $anutrigenetics
610   $atype 2 diabetes
610   $astatins
610   $asphingomyelin
610   $ahepatic fibrosis
610   $adiabetes
700   $aBakillah$b Ahmed$4auth$01287692
906   $aBOOK
912   $a9910367751903321
996   $aNew Lipid Lowering Therapies for Cardiovascular and Metabolic Diseases: Lessons from the Past and Future Challenges$93020303
997   $aUNINA